Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

JAKAVI for Myelofibrosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 98 adverse event reports in the FDA FAERS database where JAKAVI was used for Myelofibrosis.

Most Reported Side Effects for JAKAVI

Side Effect Reports % Deaths Hosp.
Death 30 20.3% 30 11
Platelet count decreased 22 14.9% 7 9
Anaemia 17 11.5% 4 10
Splenomegaly 16 10.8% 1 5
Haemoglobin decreased 13 8.8% 4 5
Cardiac failure 9 6.1% 5 5
Dyspnoea 9 6.1% 1 5
Thrombocytopenia 9 6.1% 3 6
Pyrexia 8 5.4% 3 5
Fatigue 7 4.7% 2 3
Myelofibrosis 7 4.7% 3 0
Pain 7 4.7% 4 1
Pneumonia 7 4.7% 2 4
Asthenia 6 4.1% 2 4
Drug ineffective 6 4.1% 0 1

Other Drugs Used for Myelofibrosis

RUXOLITINIB (21,650) PACRITINIB (1,586) JAKAFI (1,314) FEDRATINIB (682) MOMELOTINIB (526) LENALIDOMIDE (496) THALIDOMIDE (349) DEFERASIROX (150) HYDROXYUREA (129) AZACITIDINE (94)

Related Pages

JAKAVI Full Profile All Myelofibrosis Drugs JAKAVI Demographics JAKAVI Timeline